Furthermore, the importance of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling for maintaining the CSC phenotype in renal cell cancer (138), prostate cancer (139), and lung cancer (140) has been confirmed. The gene discussed is MTOR; the disease is prostate cancer.